AGENUS INC Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
AGENUS INC (AGEN) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-18.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-03-18
- AGENUS INC income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was $0.00.
- AGENUS INC income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was $0.00.
- AGENUS INC income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was $0.00.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 |
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 |
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |